Skip to main content Skip to main navigation menu Skip to site footer
Journal of Pharmacovigilance & Drug Safety
  • Home
  • Editorial Team
  • About
    • About the Journal
    • Privacy Statement
    • Contact
  • Articles
    • Current
    • Online Ahead
  • Archives
  • Submissions
  • Subscription
  • Policies
    • Publication & Editorial Policy
    • Open Access Policy
    • Anti Plagiarism Policy
  • For Authors
    • Author Guidelines
    • Publication Ethics
  • For Reviewers
    • Join as a Reviewer
    • Peer Review Policy
Search
  • Register
  • Login
  1. Home /
  2. Archives /
  3. Volume 21 | Issue 2 | 2024

Published: 2024-12-16

REVIEW ARTICLES

  • Developments in Inhalational Devices: Consequences for the Treatment of Chronic Obstructive Pulmonary Disease
    Vibhu Pandey, Jameel Ahmad
    1-5
    • PDF

CASE SERIES

  • A Case Series of Contact Irritant Dermatitis due to Latex Gloves: An Implication of Materiovigilance
    Ahmad Najmi, Shilpa Kaore, Balakrishnan S, Mohammad Faizan Khan
    6-7
    • PDF

CASE REPORT

  • Anaphylactic Reaction Caused by Co-administration of Diclofenac and Ofloxacin
    Gufran Ali, Irfan Ahmad Khan, Shahzad F. Haque
    8-10
    • PDF
  • Steroid-Induced Glaucoma in Asthma: A Case Report Highlighting the Steroid-Sparing and Disease-Modifying Potential of Allergen Immunotherapy
    Shambo Samrat Samajdar, Shatavisa Mukherjee, Rupak Chatterjee, Saibal Moitra, Shashank R Joshi
    11-14
    • PDF
  • Comparison of Efficacy of Prolonged Release Diclofenac Tablet, Zerodol - SP tablet, and Hot fomentation with Salt in the management of Acute Gout Attack
    Sulthan Al Rashid, Syed Ziaur Rahman
    15-17
    • PDF
  • A Case Report of Delayed-Onset Cardiotoxicity Following Long-Term Use of 5-Fluorouracil: Underlining the Importance of Long-Term Pharmacovigilance
    Aditya Vikram Singh, Farida Ahmad, Syed Shariq Naeem, Mohammad Akram
    18-19
    • PDF

SHORT COMMUNICATIONS

  • Fourth National Pharmacovigilance Week Celebration by ADR Monitoring Centre, JNMC, AMU, Aligarh
    Syed Ziaur Rahman, Gufran Ali
    20-25
    • PDF
Open Journal Systems

 

Journal of Pharmacovigilance & Drug Safety (JPDS)
(Official Publication of Society of Pharmacovigilance, India)

ISSN (online): 2584-248X 
ISSN (Print): 0972-8899
ISSUES: 2/year 
Doi: 10.21276/JPDS
Editor-in-Chief: Prof. (Dr.) Rabinarayan Acharya, MD, PhD 
Publisher:
Society of Pharmacovigilance, India

Publisher Address: Department of Pharmacology, Jawahar Lal Nehru Medical College, Aligarh Muslim University, Aligarh 202002

Website: https://amu.ac.in/department/pharmacology/journals

 

Abstracting & Indexing:

Index Copernicus

Google Scholar

 

 

 

Journal of Pharmacovigilance & Drug Safety

(Official Publication of Society of Pharmacovigilance, India)

Organization website: https://sopi.net.in/sopi-journal.html

Subject/Areas of Publication: Medical Sciences

The journal includes: 

  • Pharmacovigilance signal
  • Pharmacovigilance Data Management
  • Adverse Drug Reaction
  • Adverse Events
  • Risk assessment and management
  • Drug Informatics
  • Epidemiological Methods
  • Clinical drug manifestations of adverse drug reactions
  • Post marketing surveillance
  • Medical evaluation of adverse events
  • Pharmacogenetics
  • Pharmacogenomics
  • Materiovigilance
  • Evopharmacovigilance
  • Herbal drugs safety

Make a Submission
Information
  • For Readers
  • For Authors
  • For Librarians
Current Issue
  • Atom logo
  • RSS2 logo
  • RSS1 logo

Journal of Pharmacovigilance & Drug Safety (ISSN 0972-8899) is published by the Society of Pharmacovigilance, India (SOPI)

 

 

About this Publishing System